The influence of HLA genotype on AIDS.

Genetic resistance to infectious diseases is likely to involve a complex array of immune-response and other genes with variants that impose subtle but significant consequences on gene expression or protein function. We have gained considerable insight into the genetic determinants of HIV-1 disease, and the HLA class I genes appear to be highly influential in this regard. Numerous reports have identified a role for HLA genotype in AIDS outcomes, implicating many HLA alleles in various aspects of HIV disease. Here we review the HLA associations with progression to AIDS that have been consistently affirmed and discuss the underlying mechanisms behind some of these associations based on functional studies of immune cell recognition.

[1]  R. Pitchappan,et al.  Association of pulmonary tuberculosis and HLA in south India. , 1991, Tubercle.

[2]  I P Keet,et al.  Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. , 1994, The Journal of infectious diseases.

[3]  S. H. van der Burg,et al.  Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. , 1998, The Journal of general virology.

[4]  R. Winchester,et al.  Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[6]  R. Obst,et al.  TAP polymorphism does not influence transport of peptide variants in mice and humans , 1995, European journal of immunology.

[7]  Jeremy MG Taylor,et al.  Resistance to HIV‐1 Infection , 1994 .

[8]  Andrew J. McMichael,et al.  Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.

[9]  M. Carrington,et al.  Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. , 1995, American journal of human genetics.

[10]  B. Autran,et al.  Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. , 1999, Blood.

[11]  R. Phillips,et al.  Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. , 1996, AIDS research and human retroviruses.

[12]  Anthony S. Fauci,et al.  Toward an Understanding of the Correlates of Protective Immunity to HIV Infection , 1996, Science.

[13]  N. Nagelkerke,et al.  Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. , 1998, The Journal of infectious diseases.

[14]  S. O’Brien,et al.  Polygenic and multifactorial disease gene association in man: Lessons from AIDS. , 2000, Annual review of genetics.

[15]  Alessandro Sette,et al.  Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.

[16]  J. Just.  Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA [corrected]. , 1995, Human immunology.

[17]  Tao Dong,et al.  Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 , 2002, AIDS.

[18]  R. Kaul,et al.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. , 2001, The Journal of clinical investigation.

[19]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[20]  B. Walker,et al.  HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the Other , 2000, Journal of Virology.

[21]  G. Cooke,et al.  Genetics of susceptibitlity to human infectious disease , 2001, Nature Reviews Genetics.

[22]  Edward C. Holmes,et al.  Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.

[23]  J. Goedert,et al.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.

[24]  S. Rowland-Jones,et al.  HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.

[25]  W. Klitz,et al.  High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci. , 2000, Tissue antigens.

[26]  H C Thomas,et al.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. , 1995, The New England journal of medicine.

[27]  N. Michael,et al.  Host genetic influences on HIV-1 pathogenesis. , 1999, Current opinion in immunology.

[28]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[29]  J. Morvan,et al.  Cross-Reactions between the Cytotoxic T-Lymphocyte Responses of Human Immunodeficiency Virus-Infected African and European Patients , 1998, Journal of Virology.

[30]  A. Meyerhans,et al.  Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. , 1995, Journal of immunology.

[31]  K Bebenek,et al.  The accuracy of reverse transcriptase from HIV-1. , 1988, Science.

[32]  M. Mulligan,et al.  Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines , 2001, Journal of Virology.

[33]  G. Gerken,et al.  HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. , 1997, Journal of hepatology.

[34]  Andrew J. McMichael,et al.  HLA Leaves Its Footprints on HIV , 2002, Science.

[35]  I. Keet,et al.  The role of host genetics in the natural history of HIV‐1 infection: the needles in the haystack , 1996, AIDS.

[36]  R. Brettle,et al.  Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission. , 2001 .

[37]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.

[38]  John F. B. Mitchell,et al.  Quantifying the uncertainty in forecasts of anthropogenic climate change , 2000, Nature.

[39]  D. Vlahov,et al.  Perspectives on infection with HIV-1 among intravenous drug users. , 1988, Psychopharmacology bulletin.

[40]  H. Rammensee,et al.  Peptide motifs of HLA-B35 and-B37 molecules , 2004, Immunogenetics.

[41]  Rodney Phillips,et al.  Co‐evolution of human immunodeficiency virus and cytotoxic T‐lymphocyte responses , 1997, Immunological reviews.

[42]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[43]  J. Goedert,et al.  Concordance of human leukocyte antigen haplotype‐sharing, CD4 decline and AIDS in hemophilic siblings , 1995, AIDS.

[44]  J. Goedert,et al.  Racial differences in HLA class II associations with hepatitis C virus outcomes. , 2001, The Journal of infectious diseases.

[45]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[46]  R. Kaul,et al.  HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1 , 2000, The Journal of Immunology.

[47]  B. Walker,et al.  Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development , 1997, Journal of virology.

[48]  M. Nei,et al.  Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Klein.  Natural history of the major histocompatibility complex , 1986 .

[50]  Don C. Wiley,et al.  Atomic structure of a human MHC molecule presenting an influenza virus peptide , 1992, Nature.

[51]  J J Goedert,et al.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.

[52]  F. Marincola,et al.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Carrington,et al.  HLA and AIDS: a cautionary tale. , 2001, Trends in molecular medicine.

[54]  S. Rowland-Jones,et al.  Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. , 2000, The Journal of infectious diseases.

[55]  A. Sette,et al.  Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. , 2001, The Journal of clinical investigation.

[56]  M. Nei,et al.  Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection , 1988, Nature.

[57]  M. Carrington,et al.  Considering genetic profiles in functional studies of immune responsiveness to HIV-1. , 2001, Immunology letters.

[58]  P. Donaldson,et al.  Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. , 1998, Journal of hepatology.

[59]  A. Hughes,et al.  Natural selection at major histocompatibility complex loci of vertebrates. , 1998, Annual review of genetics.

[60]  E. Rosenberg,et al.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Zinkernagel,et al.  Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex , 1975, Nature.

[62]  R. Winchester,et al.  HLA-B35 is associated with accelerated progression to AIDS. , 1992, Journal of acquired immune deficiency syndromes.

[63]  C. Melief,et al.  Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. , 1996, Journal of immunology.

[64]  B. Dupont,et al.  Immunobiology of HLA , 1989, Springer New York.

[65]  J. Frelinger,et al.  Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians , 1997, Journal of virology.

[66]  S. Rowland-Jones,et al.  Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. , 1998, The Journal of clinical investigation.

[67]  S. O’Brien,et al.  The effect of genetic variation in chemokines and their receptorson HIV transmission and progression to AIDS , 2000, Immunological reviews.

[68]  R. Zinkernagel,et al.  A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS , 1975, The Lancet.

[69]  T. Ohta,et al.  Population Biology of Antigen Presentation by MHC Class I Molecules , 1996, Science.

[70]  Austin L. Hughes,et al.  Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection , 2002, Nature Medicine.

[71]  B. Korber,et al.  Influence of HLA Alleles on the Rate of Progression of Vertically Transmitted HIV Infection in Children: Association of Several HLA-DR13 Alleles with Long-Term Survivorship and the Potential Association of HLA-A2301 with Rapid Progression to AIDS , 1997 .

[72]  L. Loeb,et al.  Fidelity of HIV-1 reverse transcriptase. , 1988, Science.

[73]  G Hermanson,et al.  Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.

[74]  James McCluskey,et al.  Optimization of the MHC class I peptide cargo is dependent on tapasin. , 2002, Immunity.

[75]  D. Costagliola,et al.  Progression to AIDS in French haemophiliacs: association with HLA-B35. , 1993, AIDS.

[76]  E Lanino,et al.  Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.

[77]  E. Karita,et al.  HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. , 1999, AIDS research and human retroviruses.

[78]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[79]  Mark Thursz,et al.  Influence of MHC class II genotype on outcome of infection with hepatitis C virus , 1999, The Lancet.

[80]  M. Carrington,et al.  Taxonomic hierarchy of HLA class I allele sequences , 1999, Genes and Immunity.

[81]  E. Karita,et al.  HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. , 1999, AIDS.

[82]  P. Parham,et al.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.

[83]  M. Moroni,et al.  HLA-ASSOCIATED SUSCEPTIBILITY TO ACQUIRED IMMUNODEFICIENCY SYNDROME IN ITALIAN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION , 1986, The Lancet.

[84]  N. Huskisson,et al.  Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.

[85]  Rolf M. Zinkernagel,et al.  Immunology Taught by Viruses , 1996, Science.

[86]  Erin L. Schenk,et al.  HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. , 2002, Human immunology.

[87]  S. Rowland-Jones,et al.  Role of cellular immunity in protection against HIV infection. , 1997, Advances in immunology.

[88]  P. Terasaki,et al.  HLA and Disease Associations , 1985, Springer New York.

[89]  A Sette,et al.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.

[90]  D. Nixon,et al.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.

[91]  N. Nagelkerke,et al.  The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. , 2001, The Journal of infectious diseases.

[92]  Michael Bunce,et al.  Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.

[93]  M. Petzl-Erler,et al.  Association of leprosy with HLA-DR2 in a Southern Brazilian population. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[94]  M. Aidoo,et al.  Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.

[95]  J. Goedert,et al.  Characterization of high-risk HIV-1 seronegative hemophiliacs. , 2001, Clinical immunology.

[96]  S. Rowland-Jones,et al.  Cellular immune responses to HIV , 2001, Nature.

[97]  William S. Lane,et al.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.

[98]  S O'Brien,et al.  New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.